---
layout: splash
title: 대웅제약 (069620)
excerpt: 대웅제약의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 대웅제약, 069620
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 101,500 | <span style="color: tomato">0.9<small>%</small></span> | P:의약품 | 9.5 | 1.5 | 0.6<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 양약, 의료기기 제조/화장품, 의약부의품 도소매/부동산 임대 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2002년 11월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 이창재, 박성수 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.daewoong.co.kr](http://www.daewoong.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 06&#x2011;27 | | [지속가능경영보고서등관련사항(자율공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240627800308){:target="_blank"} |
| 06&#x2011;25 | | [투자판단관련주요경영사항              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240625800208){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![069620](/stock/images/069620.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 101,500 | <span style="color: tomato">0.9<small>%</small></span> | <span style="color: cornflowerblue">-1.0<small>%</small></span> | <span style="color: cornflowerblue">-4.7<small>%</small></span> | <span style="color: cornflowerblue">-16.9<small>%</small></span> | <span style="color: cornflowerblue">-13.1<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-1.8<small>%</small></span> | 32.3<small>%</small> | -0.06 | -20.7<small>%</small> | -7.4<small>%</small> | 0.1 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 9.5 | 1.5 | 0.6<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/069620/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=069620){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A069620&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=069620){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/069620){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/069620/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![069620](/stock/images/069620_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -1.8<small>%</small> | 32.3<small>%</small> | -0.06 | -20.7<small>%</small> | -7.4<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -6.3<small>%</small> | 31.0<small>%</small> | -0.20 | -21.1<small>%</small> | -8.0<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -4.7<small>%</small> | 21.0<small>%</small> | -0.22 | -18.4<small>%</small> | -7.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -1.4<small>%</small> | 19.6<small>%</small> | -0.07 | -19.8<small>%</small> | -7.1<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -16.3<small>%</small> | 21.0<small>%</small> | -0.78 | -20.9<small>%</small> | -13.5<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -17.6<small>%</small> | 21.5<small>%</small> | -0.82 | -21.9<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -17.5<small>%</small> | 21.3<small>%</small> | -0.82 | -20.5<small>%</small> | -12.3<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -8.4<small>%</small> | 17.7<small>%</small> | -0.48 | -17.6<small>%</small> | -4.4<small>%</small> |
| MACD[^fn_tech_metric_macd] | -13.6<small>%</small> | 20.7<small>%</small> | -0.66 | -25.0<small>%</small> | -12.0<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![069620](/stock/images/069620_corr.png){: .align-center}

|       | [녹십자홀딩스](/005250/) | [대웅](/003090/) | [한미약품](/128940/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [CJ대한통운](/000120/) | [DGB금융지주](/139130/) | [한미사이언스](/008930/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![069620](/stock/images/069620_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}